MedPath

Use of Dermal Matrix in Breast Reconstruction

Not Applicable
Terminated
Conditions
Breast Cancer
Registration Number
NCT00692692
Lead Sponsor
Vanderbilt University
Brief Summary

We propose to evaluate the question of whether there is a significant difference between the traditional method of serratus flap tissue expander reconstruction and the acellular matrix method.

Detailed Description

We propose a double blinded, randomized study of 60 women comparing outcomes which will include postoperative pain, complication rates and aesthetic outcome as assessed by the patient and a plastic surgeon blinded to the method of reconstruction.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
36
Inclusion Criteria
  • All women who are candidates for breast reconstruction using tissue expanders after mastectomy
Exclusion Criteria
  • Other forms of breast reconstruction after mastectomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Post Surgical Infection4 weeks

Number of participants with post surgical infection

Patient Satisfaction With the Procedureone year from time of operation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.